Rankings
▼
Calendar
ANIK FY 2019 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$208M
FY 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$115M
+8.6% YoY
Gross Profit
$86M
74.9% margin
Operating Income
$34M
29.9% margin
Net Income
$27M
23.7% margin
EPS (Diluted)
$1.89
Cash Flow
Operating Cash Flow
$37M
Free Cash Flow
$34M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$331M
Total Liabilities
$42M
Stockholders' Equity
$288M
Cash & Equivalents
$157M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$115M
$106M
+8.6%
Gross Profit
$86M
$74M
+15.6%
Operating Income
$34M
$22M
+57.5%
Net Income
$27M
$19M
+45.2%
← Q4 2018
All Quarters
Q1 2019 →